Biosero

Biosero

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $55M

Overview

Biosero is a private, revenue-generating company specializing in lab automation software and integrated robotic systems. Founded in 2003 and headquartered in San Diego, California, the company has established itself as a key enabler for digital labs, serving a global clientele across pharma, diagnostics, and life sciences. Its primary offering is the Green Button Go platform, which includes Scheduler and Orchestrator software to design, manage, and execute automated workflows. Biosero operates a services and platform business model, providing both its software and expert design/build services for custom automated workcells.

Digital HealthAI / Machine Learning

Technology Platform

Green Button Go (GBG) platform, comprising GBG Scheduler for workcell automation and GBG Orchestrator for lab-wide workflow integration. It features drag-and-drop configuration, a library of hundreds of device drivers, real-time monitoring, and API connectivity to LIMS, ELN, and AI software.

Funding History

2
Total raised:$55M
Series B$35M
Series A$20M

Opportunities

The growing demand for lab digitization, AI/ML integration, and complex biological workflows (e.g., cell therapy, genomics) drives need for robust orchestration software.
Expansion into new verticals like diagnostics and biobanking, and offering data analytics services on top of its platform, present significant growth avenues.

Risk Factors

Faces competition from large instrument vendors with proprietary software and other automation software firms.
Relies on seamless integration with third-party hardware, making it vulnerable to API changes or lack of cooperation.
Business is cyclical and tied to customers' R&D capital expenditure.

Competitive Landscape

Competes with automation software from large integrated vendors (Thermo Fisher, Beckman Coulter, Agilent) and other software-focused firms like HighRes Biosolutions, Synthace, and Automata. Differentiation lies in hardware agnosticism, a broad driver library, and scalable solutions from single workcells to enterprise orchestration.